Nuvigil: Careful or calculating?

The drug’s approved, but not available until 2010. The WSJ Health Blog speculates why:

We can’t help noticing that Provigil, a Cephalon drug that alleviates sleepiness and is very similar to Nuvigil, will face generic competition in 2012. As Megan Murphy of Lazard Capital Markets pointed out in a note this morning, bringing Nuvigil (patent protected until 2023) to the market in 2010 would give the company just enough time to get Provigil patients to switch over to Nuvigil before generic Provigil hits the market.

Related posts:

1. Does jet lag really need to be cured?
2. How pharmaceuticals are maximizing profits in anticipation of competition from generics
3. Pfizer using doctors as a "human shield"?
4. Music to Lipitor’s ears
5. The fight against generics
6. Are generic drugs truly equivalent to brand name medications?
7. "Pay to delay": How Big Pharma is paying off generic drug companies

  Follow on Twitter   Subscribe

Tagged as: patient